| Amneal Pharmaceuticals, Inc. (AMRX) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | ||||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | ||||||||||||||||
| Price to Sales | 1.44x | 1.31x | 1.07x | .89x | .92x | .88x | .96x | .76x | .74x | .78x | .27x | .20x | .09x | .14x | .14x | .22x | .30x | .34x | .38x | .37x | .50x | .34x | .30x | .40x | .29x | .39x | .21x | .50x | 1.97x | 1.03x | - | - | |||||||||||||||||
| Price to Book | - | - | - | - | - | - | - | - | - | 94.07x | 1.96x | 1.48x | .72x | 1.01x | 1.03x | 1.70x | 1.59x | 1.98x | 2.27x | 2.19x | 3.08x | 2.23x | 1.90x | 2.29x | 1.55x | 2.72x | 1.70x | 1.99x | 7.64x | 3.41x | - | - | |||||||||||||||||
| Price to Earnings | 60.39x | 54.93x | 533.40x | 752.21x | - | - | - | - | - | - | 62.77x | - | - | - | - | - | 353.55x | 67.31x | 56.87x | 82.14x | - | 7.44x | 9.22x | - | - | - | - | - | - | - | - | - | |||||||||||||||||
| Price to Unlevered FCF | 16.12x | 14.66x | 11.91x | 8.97x | 10.35x | 10.10x | 9.67x | 9.30x | 11.68x | 6.15x | 4.57x | 3.23x | 5.42x | 16.08x | 3.10x | 4.93x | 3.72x | 3.68x | 3.53x | 4.06x | 2.38x | 2.10x | 2.99x | 2.47x | 4.03x | - | 1.49x | 5.78x | 46.67x | 8.14x | - | - | |||||||||||||||||
| Debt to Asset Ratio | 1.02x | 1.03x | 1.03x | 1.04x | 1.03x | 1.03x | 1.02x | 1.02x | .99x | .96x | .96x | .96x | .95x | .95x | .96x | .90x | .91x | .90x | .90x | .91x | .91x | .91x | .91x | .91x | .91x | .89x | .82x | .82x | .79x | .80x | .79x | - | |||||||||||||||||
| Current Ratio | 2.17x | 2.13x | 1.43x | 1.40x | 1.41x | 1.38x | 1.33x | 1.65x | 1.63x | 1.91x | 1.83x | 1.86x | 1.88x | 1.74x | 1.56x | 2.31x | 2.24x | 2.35x | 2.32x | 2.45x | 2.29x | 2.31x | 2.26x | 1.84x | 2.20x | 2.25x | 2.17x | 2.11x | 2.32x | 1.91x | 2.01x | 2.60x | |||||||||||||||||